Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 6 results:
Author Title Type [ Year(Desc)]
Filters: Author is Whittle, R.  [Clear All Filters]
2017
A. A. Sultan, Mallen, C., Hayward, R., Muller, S., Whittle, R., Hotston, M., and Roddy, E., “Gout and subsequent erectile dysfunction: a population-based cohort study from England”, Arthritis Res Ther, vol. 19, p. 123, 2017.
2018
M. Roughley, Sultan, A. A., Clarson, L., Muller, S., Whittle, R., Belcher, J., Mallen, C. D., and Roddy, E., “Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study”, Arthritis Res Ther, vol. 20, p. 243, 2018.
Z. Paskins, Whittle, R., Sultan, A. A., Muller, S., Blagojevic-Bucknall, M., Helliwell, T., Hider, S., Roddy, E., and Mallen, C., “Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study”, BMC Med, vol. 16, p. 4, 2018.
A. A. Sultan, Whittle, R., Muller, S., Roddy, E., Mallen, C. D., Bucknall, M., Helliwell, T., Hider, S., and Paskins, Z., “Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy”, Cmaj, vol. 190, pp. E581-e587, 2018.
Z. Paskins, Whittle, R., A. Sultan, A., Muller, S., Blagojevic-Bucknall, M., Helliwell, T., Packham, J., Hider, S., Roddy, E., and Mallen, C., “Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study”, Osteoporos Int, vol. 29, pp. 1659-1664, 2018.
2019
A. A. Sultan, Muller, S., Whittle, R., Roddy, E., Mallen, C., and Clarson, L., “Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy”, Cmaj, vol. 191, pp. E597-e603, 2019.
[Page last reviewed 4 October 2019]